SCHEMBL8501209

SCHEMBL8501209

CC(C(=O)O)c1ccc2ncc(-c3cccc(F)c3)cc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 12/20 0.60
AKR1C2 P52895 12/20 0.60
PDGFRB P09619 1/20 0.50
PDGFRA P16234 1/20 0.50
PTGS1 P23219 3/20 0.47
PTGS2 P35354 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
FABP2 P12104 1/20 0.47
TSHR P16473 1/20 0.47
AKR1C4 P17516 1/20 0.47
ADRA2B P18089 1/20 0.47
CHRM3 P20309 1/20 0.47
HTR2C P28335 1/20 0.47
DRD3 P35462 1/20 0.47
AKR1C1 Q04828 1/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8501617 0.89 AKR1C3 (0.58) AKR1C3AKR1C2PDGFRBPDGFRAPTGS1
SCHEMBL8889529 0.85 FFAR1 (0.48) AKR1C3AKR1C2PDGFRBPDGFRAMAP4K4
SCHEMBL8889522 0.80 PDGFRB (0.47) AKR1C3AKR1C2PDGFRBPDGFRAMAP4K4
Fluprofen SCHEMBL29357121 0.79 PTGS2 (0.69) AKR1C3AKR1C2PTGS1PTGS2MEN1
Fluprofen SCHEMBL416261 0.79 PTGS2 (0.69) AKR1C3AKR1C2PTGS1PTGS2MEN1
SCHEMBL8499693 0.78 PDGFRB (0.52) PDGFRBPDGFRAHPGDMAP4K4CSNK1G2
SCHEMBL8887119 0.78 PDGFRB (0.47) PDGFRBPDGFRAMAP4K4CSNK1G2CLK4
SCHEMBL8889438 0.77 PDGFRB (0.55) PDGFRBPDGFRAMAP4K4CSNK1G2CLK4
SCHEMBL8502976 0.77 AKR1C3 (0.44) AKR1C3AKR1C2PDGFRBPDGFRAPTGS2
SCHEMBL8890269 0.75 FFAR1 (0.48) AKR1C3AKR1C2PDGFRBPDGFRAMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed